Skip to main content
Veterinary Medicines

BAYCOX 25mg/ml peroralna raztopina za piščance in purane

Authorised
  • Toltrazuril

Product identification

Medicine name:
BAYCOX 25mg/ml peroralna raztopina za piščance in purane
Active substance:
  • Toltrazuril
Target species:
  • Chicken
  • Turkey
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Toltrazuril
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        14
        day
    • Turkey
      • Meat and offal
        16
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51BC01
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Available in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • NP/V/0029/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 9/11/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 9/11/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 9/11/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."